Leuprolide Acetate Market Trends

  • Report ID: 5156
  • Published Date: Apr 18, 2025
  • Report Format: PDF, PPT

Leuprolide Acetate Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Demand for IVF Treatment – It is expected that the growing incidence of infertility owing to lifestyle changes, may drive market growth. 

  • Leuprolide acetate injection is a synthetic gonadotropin-releasing hormone that can be used to mature the eggs for retrieval. Moreover, lupron is an injectable fertility drug that is in the category of GnRH agonists which reduces the production of estrogen and progesterone by the ovaries. Over the past five years, IVF cycles have climbed at a pace of over 23%, and India is now ranked third globally for IVF procedures.

  • Growing Geriatric Population- Hormone-related disorders are more common in older people, and the rising elderly population is expected to increase the demand for leuprolide acetate since it is used to manage hormonal imbalances.
  • The number of individuals in the world who are 60 or older will reach over 2 billion by 2050.

Challenges

  • Risk of Potential Side Effects- Leuprolide acetate may cause several side effects such as breast swelling or tenderness, hot flashes, increased bone pain, increased difficulty passing urine, or an aggravation of nerve symptoms, which may hamper the market growth.

  • Stringent Price Control Policies

  • Availability of Alternative Treatments

Base Year

2024

Forecast Year

2025-2037

CAGR

6.8%

Base Year Market Size (2024)

USD 2.3 billion

Forecast Year Market Size (2037)

USD 5.41 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

2025 Leuprolide Acetate Market is evaluated at USD 2.43 billion.

The global leuprolide acetate market size was over USD 2.3 billion in 2024 and is forecast to experience a CAGR of over 6.8%, reaching USD 5.41 billion by 2037.

North America is forecasted to amass USD 2.16 billion by 2037, fueled by rising healthcare spending, improving medical access, and the diagnosis of diseases such as prostate cancer and fertility issues.

The major players in the market are Ferring B.V., Sun Pharmaceutical Industries Ltd., Beijing Biote Pharmaceutical Co., Ltd., Anhui Anke Bioengineering (Group) Co., Ltd., AbbVie Inc., Merck & Co., Inc., Taj Pharmaceuticals Limited., Zydus Group, Cipla Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos
GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

See our insights in action - schedule your demo now!

Live Sample Reading